logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available [see all tables in this series...]

Part (vi) New inpatient clients, primary drug distribution by age (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opioids9.525.346.560.057.853.950.833.5366724
Cocaine0.02.95.77.010.311.813.14.15424
Stimulants21.424.820.313.411.210.27.68.4116411
Hypnotics and sedatives9.51.92.62.54.67.38.330.64452
Hallucinogens1.20.20.40.10.00.00.20.2140
Volatile substances28.68.51.51.00.90.31.00.21731
Cannabis 26.234.821.314.112.113.213.312.413725
Other substances 3.61.61.71.83.03.25.710.62341
Total84989183718871202627421564761148

Notes:

 The countries supplying data are: 

 BG, CZ, DK, DE, IE, EL, FR, CY, LV,HU, AT, RO, SK, FI, SE, UK, HR, TR. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-104 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2009 — Table TDI outpatient and inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 14 July 2010